These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14563997)

  • 1. Medicine. PPARs as therapeutic targets: reverse cardiology?
    Plutzky J
    Science; 2003 Oct; 302(5644):406-7. PubMed ID: 14563997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta.
    Lee CH; Chawla A; Urbiztondo N; Liao D; Boisvert WA; Evans RM; Curtiss LK
    Science; 2003 Oct; 302(5644):453-7. PubMed ID: 12970571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of macrophage cholesterol trafficking by PPARalpha and LXR.
    Chinetti G; Fruchart JC; Staels B
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1128-31. PubMed ID: 17073767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orphan nuclear receptors find a home in the arterial wall.
    Laffitte BA; Tontonoz P
    Curr Atheroscler Rep; 2002 May; 4(3):213-21. PubMed ID: 11931719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARs and other nuclear receptors in inflammation.
    Rizzo G; Fiorucci S
    Curr Opin Pharmacol; 2006 Aug; 6(4):421-7. PubMed ID: 16777482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages.
    Szanto A; Benko S; Szatmari I; Balint BL; Furtos I; Rühl R; Molnar S; Csiba L; Garuti R; Calandra S; Larsson H; Diczfalusy U; Nagy L
    Mol Cell Biol; 2004 Sep; 24(18):8154-66. PubMed ID: 15340076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
    Chinetti G; Fruchart JC; Staels B
    Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do macrophage innate immune receptors enhance atherogenesis?
    Gordon S
    Dev Cell; 2003 Nov; 5(5):666-8. PubMed ID: 14602065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages.
    Chinetti-Gbaguidi G; Staels B
    Biochim Biophys Acta; 2009 Jun; 1791(6):486-93. PubMed ID: 19416654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.
    Ricote M; Valledor AF; Glass CK
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):230-9. PubMed ID: 14592855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of metabolism and inflammation by lipid-activated nuclear receptors.
    Bensinger SJ; Tontonoz P
    Nature; 2008 Jul; 454(7203):470-7. PubMed ID: 18650918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses.
    Bonta PI; van Tiel CM; Vos M; Pols TW; van Thienen JV; Ferreira V; Arkenbout EK; Seppen J; Spek CA; van der Poll T; Pannekoek H; de Vries CJ
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2288-94. PubMed ID: 16873729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of PPARs in atherosclerosis.
    Duval C; Chinetti G; Trottein F; Fruchart JC; Staels B
    Trends Mol Med; 2002 Sep; 8(9):422-30. PubMed ID: 12223313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LXRs: new therapeutic targets in atherosclerosis?
    Joseph SB; Tontonoz P
    Curr Opin Pharmacol; 2003 Apr; 3(2):192-7. PubMed ID: 12681243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77.
    Pei L; Castrillo A; Tontonoz P
    Mol Endocrinol; 2006 Apr; 20(4):786-94. PubMed ID: 16339277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.
    Rigamonti E; Chinetti-Gbaguidi G; Staels B
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1050-9. PubMed ID: 18323516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
    Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
    Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the LXRalpha protein in human atherosclerotic lesions.
    Watanabe Y; Jiang S; Takabe W; Ohashi R; Tanaka T; Uchiyama Y; Katsumi K; Iwanari H; Noguchi N; Naito M; Hamakubo T; Kodama T
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):622-7. PubMed ID: 15625283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of oxidized low-density lipoprotein in the activation of peroxisome proliferator-activated receptor gamma: implications for atherosclerosis.
    Wolf G
    Nutr Rev; 1999 Mar; 57(3):88-91. PubMed ID: 10101923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perplexity of monocyte responses to C-reactive protein (CRP).
    Filep JG
    Thromb Haemost; 2008 Mar; 99(3):461-2. PubMed ID: 18327390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.